Responses
Featured Posters: Poster Rounds with the Professors
AS11. Ovarian cancer
PR069/#709 Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: a Korean multicenter cohort study
Compose a Response to This Article
Other responses
No responses have been published for this article.